Considering recent advances in understanding RhoA/ROCK signaling in regulating metabolic functions, promoting brown adipogenesis and browning process of WAT by ROCK inhibition, particularly ROCK2 inhibition, have emerged as promising strategies to treat obesity and its related metabolic disorders. The gene discussed is ROCK2; the disease is obesity due to melanocortin 4 receptor deficiency.